SCHEMBL20470668

SCHEMBL20470668

C=CCC(C)(CC)c1ccc(Oc2ccc(N)cc2)cc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 5/20 0.59
▸ RAB9A P51151 4/20 0.59
▸ NPC1 O15118 3/20 0.59
▸ ALDH1A1 P00352 6/20 0.53
▸ HPGD P15428 1/20 0.53
▸ MAPK1 P28482 1/20 0.53
▸ TDP1 Q9NUW8 3/20 0.42
▸ TSHR P16473 2/20 0.42
▸ CYP3A4 P08684 1/20 0.42
▸ TEAD4 Q15561 1/20 0.41
▸ POLB P06746 3/20 0.40
▸ SMN1; SMN2 Q16637 3/20 0.39
▸ MAOA P21397 2/20 0.38
▸ KDM4E B2RXH2 1/20 0.37
▸ MAOB P27338 2/20 0.37
▸ MEN1 O00255 1/20 0.36
▸ MITF O75030 1/20 0.36
▸ GAA P10253 1/20 0.36
▸ GFER P55789 1/20 0.36
▸ KMT2A Q03164 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21166757 0.84 KDM4E (0.61) MAPTRAB9ANPC1ALDH1A1HPGD
SCHEMBL20470550 0.83 RAB9A (0.42) MAPTRAB9ANPC1ALDH1A1HPGD
SCHEMBL21166650 0.83 MAPT (0.57) MAPTRAB9ANPC1ALDH1A1HPGD
SCHEMBL21656987 0.82 PARP10 (0.50) MAPTRAB9ANPC1ALDH1A1POLB
SCHEMBL23228713 0.78 LMNA (0.43) MAPTRAB9ANPC1ALDH1A1HPGD
SCHEMBL21656877 0.77 HPGD (0.55) MAPTRAB9ANPC1ALDH1A1HPGD
SCHEMBL1857763 0.75 MAPT (0.73) MAPTRAB9ANPC1ALDH1A1HPGD
SCHEMBL15054796 0.75 MAPT (1.00) MAPTRAB9ANPC1ALDH1A1HPGD
SCHEMBL13019390 0.74 MAPT (0.53) MAPTRAB9ANPC1ALDH1A1HPGD
SCHEMBL7607195 0.73 MAPT (0.70) MAPTRAB9ANPC1ALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10274481-B2 Method for identifying modulators of notch signaling ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE (EPFL) (CH) 2019-04-30 — — US disclosed
US-20180224429-A1 INHIBITORS OF NOTCH SIGNALLING PATHWAY AND USE THEREOF IN TREATMENT OF CANCERS ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE (EPFL) (CH) 2018-08-09 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10274481-B2 Method for identifying modulators of notch signaling NOTCH3, NOTCH1, NOTCH4 MAPT 3343/4885RAB9A 3388/4885NPC1 1941/4885
US-20180224429-A1 INHIBITORS OF NOTCH SIGNALLING PATHWAY AND USE THEREOF IN TREATMENT OF CANCERS NOTCH3, NOTCH1, NOTCH4 MAPT 3407/4885RAB9A 3103/4885NPC1 2594/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback